Cargando…
Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome
Patients with atypical haemolytic uremic syndrome (aHUS) with a mutation in the gene encoding membrane cofactor protein (CD46) are known to have a better prognosis than those with mutations in factor H (CFH) or factor I (CFI), but a small number of the former still proceed to end-stage renal failure...
Autores principales: | Davin, Jean-Claude, Buter, Nynke, Groothoff, Jaap, van Wijk, Joanna, Bouts, Antonia, Strain, Lisa, Goodship, Tim |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719744/ https://www.ncbi.nlm.nih.gov/pubmed/19373492 http://dx.doi.org/10.1007/s00467-009-1188-8 |
Ejemplares similares
-
Long-term renal function under plasma exchange in atypical hemolytic uremic syndrome
por: Davin, Jean-Claude, et al.
Publicado: (2011) -
Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation
por: Davin, Jean Claude, et al.
Publicado: (2008) -
Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulation
por: Davin, Jean-Claude, et al.
Publicado: (2010) -
CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency
por: Bouts, Antonia H., et al.
Publicado: (2010) -
Exchange transfusion for neonate with haemolytic uremic syndrome
por: Saikia, Bedangshu, et al.
Publicado: (2016)